Technical Analysis for PRPH - ProPhase Labs, Inc.

Grade Last Price % Change Price Change
C 7.26 -0.82% -0.06
PRPH closed up 5.63 percent on Wednesday, July 28, 2021, on 37 percent of normal volume.
Earnings due: Aug 9
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical PRPH trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion -0.82%
Overbought Stochastic Strength -0.82%
Upper Bollinger Band Walk Strength 4.76%
Wide Bands Range Expansion 4.76%
Overbought Stochastic Strength 4.76%
Upper Bollinger Band Walk Strength -0.27%
Wide Bands Range Expansion -0.27%
Overbought Stochastic Strength -0.27%
Upper Bollinger Band Touch Strength -0.27%
Pocket Pivot Bullish Swing Setup -2.68%
Older End-of-Day Signals for PRPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Reversed from Up about 1 hour ago
Upper Bollinger Band Resistance about 2 hours ago
Rose Above 200 DMA about 4 hours ago
Possible Pocket Pivot about 5 hours ago
Rose Above Previous Day's High about 6 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


ProPhase Labs, Inc. Description

ProPhase Labs, Inc. engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public. It is also involved in the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care, and cosmeceutical products. The company offers Cold-EEZE, a zinc gluconate glycine lozenge to reduce the duration and severity of the common cold symptoms. It also markets and distributes two non-lozenge forms of its proprietary zinc gluconate formulation, Cold-EEZE daytime/nighttime QuickMelts and Cold-EEZE oral spray; and Kids-EEZE products for children suffering from upper respiratory infections, allergy, and/or chest congestion, as well as organic cough drops and a Vitamin C supplements. It also provides private label lozenge products for retail customers; and performs contract manufacturing services of cough drop and other OTC cold remedy products for third parties. ProPhase Labs, Inc. sells its products through food, multi-outlet pharmacy and chain drug stores, wholesalers, and mass merchandisers in the United States. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Products Vitamin Symptoms Allergy Dietary Supplements Contract Manufacturing Zinc Contract Manufacturing Services Cough Over The Counter Drug Respiratory Infection Upper Respiratory Infection

Is PRPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 16.04
52 Week Low 1.66
Average Volume 412,901
200-Day Moving Average 7.78
50-Day Moving Average 6.02
20-Day Moving Average 6.38
10-Day Moving Average 6.72
Average True Range 0.51
ADX 33.43
+DI 29.01
-DI 14.36
Chandelier Exit (Long, 3 ATRs) 6.41
Chandelier Exit (Short, 3 ATRs) 6.94
Upper Bollinger Bands 7.47
Lower Bollinger Band 5.30
Percent B (%b) 0.93
BandWidth 34.05
MACD Line 0.34
MACD Signal Line 0.23
MACD Histogram 0.1077
Fundamentals Value
Market Cap 84.94 Million
Num Shares 11.6 Million
EPS -0.33
Price-to-Earnings (P/E) Ratio -22.39
Price-to-Sales 8.53
Price-to-Book 9.91
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.13
Resistance 3 (R3) 8.08 7.76 7.99
Resistance 2 (R2) 7.76 7.55 7.78 7.95
Resistance 1 (R1) 7.54 7.43 7.65 7.59 7.90
Pivot Point 7.22 7.22 7.28 7.25 7.22
Support 1 (S1) 7.00 7.01 7.11 7.05 6.74
Support 2 (S2) 6.68 6.89 6.71 6.69
Support 3 (S3) 6.46 6.68 6.65
Support 4 (S4) 6.51